About this trial
CAReS (the Cancer Appetite Recovery Study) is currently enrolling adult patients in England, Scotland and Ireland who are suffering from weight loss as a result of their cancer. Cancer related anorexia is very common, but unfortunately, no approved treatment currently exists. CAReS is evaluating a new investigational medication for cancer related anorexia. The new medication is ART27.13, an oral, once-daily synthetic cannabinoid which aims to stimulate appetite in patients with cancer anorexia and weight loss.
Patient Profile
All cancers (including metastatic), with the exception of brain cancers.
Where’s this trial being run?
St James’s Hospital
Can I join this study / trial?
The first thing you do is to talk to your doctor and/or the cancer trials research team in your hospital. The contact details for the cancer trials research units in Ireland is here.
Why not Print this page and bring it with you. It will help your doctor and research team advise you.
Print this pageFor more detailed information
Click HereQuestions?
Here’s a list of questions you may have for your doctor or local cancer research team.
QuestionsSummary Data
| Name: | CAReS (The Cancer Appetite Recovery Study) |
|---|---|
| Number: | 23-07 |
| Full Title: | The Cancer Appetite Recovery Study, a randomized, double blinded, placebo-controlled trial assessing the safety and effectiveness of a new medication in cancer patients with anorexia and weight loss |
| Principal Investigator: | Prof Andrew Davies |
|---|---|
| Type: | Industry Sponsored |
| Sponsor: | Artelo Biosciences Ltd. |
| Recruitment Started: |
Global: March 2021 Ireland: May 2022 |
| Global Recruitment Target: | 43 |
|---|---|
| Ireland Recruitment Target: |